Best Nanotechnology Companies in Sweden

Graphmatech is a manufacturer of graphene-based nanocomposites materials and services with its patented material called Aros Graphene. The material which is self-lubricating, self-cooling, and light-weight exhibits thermal and electrical conductivity, high wear resistance, corrosion barrier as well as very low dry friction and can be applied as a coating, or as an additive to a matrix or even 3D-printed. It has partnered with ABB, Sandvik, National, Granges, and Wematter.

Funding rounds

• Apr 2026Series A$2.1M
• Apr 2026Grant (prize money)$4.2M
• Sep 2022Grant (prize money)$143.3K
• Jun 2021Series A$10.1M

Founders & team

Mamoun TaherFounderOlivia NestiusChief Executive Officer

Investors

Europa, EIT InnoEnergy, Walerud Ventures, Almi Invest, ABB, Molindo

Tech stack

AddtoanyCloudflareCloudflare Browser InsightsCookieyesGoogle AnalyticsGoogle Tag Manager

Developer of nanofiber-based cell culture products for upstream bioprocessing. The company's technology is scalable and customizable for research and development. It enables the development of improved cell culture products. The products are for cell and gene therapy and novel vaccines production. The company has implemented good manufacturing practice processes for production. It collaborates with contract development and manufacturing organizations and biopharmaceutical companies.

Funding rounds

• Sep 2024Seed$3.5M
• Oct 2023Seed$3.5M
• Jul 2023Seed—

Founders & team

Maximilian OttossonFounder & COOErik FredstorpFounderUwe GottschalkChairman of Board

Investors

Industrifonden, Europa, Onsight Ventures, EIC Fund, Smile Incubator

Tech stack

Apache Http ServerCookiebotCore-JsGoogle AnalyticsGoogle Font ApiGoogle Tag Manager

Provider of graphene-based 2D nanocomposite materials. It uses recycled plastic materials to develop functionalized graphene-based composite materials. It also designs and provides custom plastic blends according to the client's requirements. It has applications in oil and gas, plastic end product, and textile sectors.

Funding rounds

• Mar 2025Seed$760K

Founders & team

Elliot SparrowCo-FounderGovindan InduchoodanCo-Founder

Investors

Paulig, Chalmers Ventures, Almi Invest

Provider of nanowire-based sensors. It provides nanowire material types and dimensions to organize and align the nanowires on platforms. It also provides technology to enable nanowires to detect single molecules at an order of magnitude optical contrast. It also owns a patent regarding nanowire development.

Funding rounds

• Aug 2024Seed$389.7K
• 2023Grant (prize money)$54.6K
• Jun 2022Grant (prize money)$2.5M
• Oct 2019Seed$518.8K

Founders & team

Jaime Castillo-LeonCo-Founder & Director

Investors

Europa, SmiLe Incubator, EIC Fund, Mist Ventures, Lund University, Almi Invest

Tech stack

CloudflareCloudflare Bot ManagementCore-JsGoogle Font ApiGoogle Tag ManagerHsts

Developer of solar films made up of GaAs nanowires. It has developed a fabrication technology called Aerotaxy which creates nanomaterials by suspending materials in gases that generate nanowires which are then integrated into solar panels. It is based on wave-concentrated photovoltaics, which concentrates light waves into nanowires for absorption.

Oasmia Pharmaceutical is engaged in the development of novel anti-cancer formulations based on well-established cytostatics targeted at human and animal health. The firm's lead candidate Apealea (Paclical) is a novel formulation of Paclitaxel, based on its patented excipient platform XR-17. The company has submitted a Marketing Authorization Application to the EMA in Feb 2016. XR-17 is the company's proprietary nano-sized excipient based on Vitamin A, which is a surfactant with micelle-forming capabilities. XR-17 can form micelles with water soluble compounds also and hence it can enclose several molecules in micelles regardless of their water solubility. This would thus reduce the no. of doses, as two drug substances can be infused in one go and thus their nanoparticle-based drug delivery technology has the capability to reduce side-effects and cater to multiple therapy areas. The company has 4 other drugs in the pipeline for cancers in humans and 2 drugs for animal cancers. Oasmia has capabilities for GMP manufacture of its drugs for clinical sales and trials. The company is also developing excipients based on semi-synthetic derivatives of retinoids and polyunsaturated fatty acid

Developer of bioenergy project

Funding rounds

• Mar 2024Grant (prize money)$2.7M
• Aug 2022Seed$1.3M

Founders & team

Liam HardeyCo-Founder & CEOMagnus WikströmCo-founder & Chairman

Investors

LiU Invest, Klimatet Invest, Voima Ventures, KTH Holding, Almi Invest, European Innovation Council

Developer of nanocellulose for industrial solutions. Its products include cellulose powder that has applications in composites and packaging, nanocellulose hydrogel for inks and paints, and nanocellulose hydrogel extra pure for cosmetics. It uses the customized nanocellulose products available in tunable sizes and surface properties.

Funding rounds

• Dec 2023Series A$1.1M
• 2022Seed—
• Jun 2018Seed—

Founders & team

Kloce Dongfang LiCo-Founder & CEOMonica EkCo-Founder

Investors

EIT InnoEnergy, Gaeu Ventures, Kiram, Mets Spring, KTH Holding

Provider of smart sensors and electronic devices

Provider of polymer-based nanomaterials. It provides users with a platform that offers nanostructures using polymers such as nano-cellulose, and dendrimers. It also provides users with dendrons, mass spectrometry calibrants, and multifunctional PEGs.

Promimic uses nanotechnology to produce a nanometer thin surface coating for implants and prosthetic devices that mimics Hydroxyapatite, a compund found in human bone tissue. The surface of the implant after application of the coating resembles that of the living bone tissue. The similarity to human bone helps the body’s own bone cells grow on the implant. and can cut the healing period for implants in half. The proprietary HAnano Surface can be applied onto various types of substrates, including metals, ceramics and polymers. The product has been evaluated successfully in several preclinical studies.

Developer of nanoparticles-based solutions for drug delivery. The company has developed biological nanoparticles that may be intracellular or extracellular formed from organic or inorganic materials uses nanoparticles as carriers and deliver cargo & drugs directly into the cell. It can be used for diagnostic tests and screening of multiple diseases.